Related Experiment Video

Updated: Jun 19, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

MRI and cognitive impairment in Parkinson's disease

Naroa Ibarretxe-Bilbao1, Eduardo Tolosa, Carme Junque

  • 1Centro de Investigación en Red de Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic de Barcelona, Barcelona, Spain.

Movement Disorders : Official Journal of the Movement Disorder Society
|October 31, 2009
PubMed

Insights

Parkinson's disease (PD) patients show brain atrophy linked to cognitive decline and dementia risk. Structural MRI can identify these brain changes early, potentially serving as a marker for cognitive impairment in PD.

Area of Science:

  • Neuroimaging
  • Neurology
  • Cognitive Science

Background:

  • Parkinson's disease (PD) is associated with a significantly higher risk of dementia compared to the general population.
  • Cognitive impairments can manifest early in PD, impacting daily functioning.
  • Structural brain changes are increasingly recognized as contributors to cognitive deficits in PD.

Purpose of the Study:

  • To review structural magnetic resonance imaging (MRI) studies investigating brain changes in Parkinson's disease.
  • To correlate specific brain structural alterations with cognitive dysfunction and dementia in PD patients.
  • To evaluate the potential of structural MRI as an early diagnostic marker for dementia in Parkinson's disease.

Main Methods:

  • Review of manual region of interest (ROI) and voxel-based morphometry (VBM) studies using structural MRI in Parkinson's disease.
  • Analysis of correlations between brain atrophy (e.g., hippocampal volume) and cognitive deficits (e.g., verbal memory).
  • Comparison of brain structure in PD patients with and without dementia, cognitive impairment, or visual hallucinations.

Main Results:

  • Hippocampal volume reduction is observed in PD patients, correlating with verbal memory deficits.
  • Voxel-based morphometry studies reveal limbic area changes and widespread cortical atrophy in PD with dementia.
  • Greater brain atrophy is evident in PD patients experiencing cognitive impairment or visual hallucinations, suggesting atrophy precedes dementia.

Conclusions:

  • Cortical atrophy is closely related to cognitive dysfunction in Parkinson's disease.
  • Structural MRI findings indicate that brain atrophy can precede the clinical development of dementia in PD.
  • Structural MRI holds promise as an early predictive marker for dementia in Parkinson's disease patients.

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...